Cancer developments 

The development of our cancer services is a key strategic priority for UCLH – we have ambitions to be one of the leading cancer providers in the world.

We have everything we need to achieve this ambition – academic links to one of the world’s best universities, extensive research activity, expert staff, a state-of-the-art cancer centre, development of the UK’s first proton beam therapy service and designation as a specialist centre. Our successful bid to become a vanguard (with The Christie and Royal Marsden) puts us in a position to lead the development of a model of cancer services for others to follow which will lead to earlier diagnosis and better outcomes.

The UCLH cancer strategy 2015 - 2020 sets out our plans for the next five years, and how we will achieve them.

UCLH works within a system of hospitals including The Royal London, St Bartholomew’s, The Royal Free and Queen’s Hospital in Romford to provide cancer services to people who live in north and east London and West Essex. We are a specialist treatment centre for five types of cancer, as listed below.

This ‘system’ approach means that patients have some of their cancer treatment at their local hospital but may be treated at UCLH for specialist treatment, for example, surgery or specialist radiotherapy. This approach to cancer care was developed by NHS England and was implemented in 2015 (with the exception of brain cancer surgery, which will transfer to UCLH in summer 2017) with the aim of saving more lives, helping to achieve improvements in the quality of services and making best use of the expertise available locally – click here to find out more.

Any updates about the centralisation of services will be posted on the cancer services blog.